Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-J Hao

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 9, 2013
Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinomaZ-Z Shi, Y-Y Jiang, J-J Hao, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 1, 2026
[Drug resistance characteristics of rilpivirine in HIV-1-infected patients before starting antiretroviral therapy in nine provinces of China]J L Li, J J Hao, J Hu, et al.
Journal of Thrombosis and Haemostasis : JTH|January 22, 2017
Expression and characterization of a codon-optimized blood coagulation factor VIIIS A Shestopal, J-J Hao, E Karnaukhova, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 19, 2016
[Expression and intratumoral heterogeneity of LN-5γ2 in esophageal squamous cell carcinoma]C C Lu, L F Wu, C Chang, et al.
Oncogene|August 18, 2009
Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinomaX-L Du, H Yang, S-G Liu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 29, 2022
[Effects of pretreatment HIV drug resistance on the virological response of HIV-infected patients after 3-year antiretroviral therapy]H L Chen, Y S Zhou, J J Hao, et al.
Oncogene|October 24, 2017
Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferationF Shi, L Shang, L-Y Yang, et al.
Oncogene|February 16, 2016
Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinomaY-Y Jiang, L Shang, Z-Z Shi, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 9, 2013
Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinomaZ-Z Shi, Y-Y Jiang, J-J Hao, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 1, 2026
[Drug resistance characteristics of rilpivirine in HIV-1-infected patients before starting antiretroviral therapy in nine provinces of China]J L Li, J J Hao, J Hu, et al.
Journal of Thrombosis and Haemostasis : JTH|January 22, 2017
Expression and characterization of a codon-optimized blood coagulation factor VIIIS A Shestopal, J-J Hao, E Karnaukhova, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 19, 2016
[Expression and intratumoral heterogeneity of LN-5γ2 in esophageal squamous cell carcinoma]C C Lu, L F Wu, C Chang, et al.
Oncogene|August 18, 2009
Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinomaX-L Du, H Yang, S-G Liu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 29, 2022
[Effects of pretreatment HIV drug resistance on the virological response of HIV-infected patients after 3-year antiretroviral therapy]H L Chen, Y S Zhou, J J Hao, et al.
Oncogene|October 24, 2017
Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferationF Shi, L Shang, L-Y Yang, et al.
Oncogene|February 16, 2016
Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinomaY-Y Jiang, L Shang, Z-Z Shi, et al.
Pageof 3